AKNA Is a Potential Prognostic Biomarker in Gastric Cancer and Function as a Tumor Suppressor by Modulating EMT-Related Pathways

Table 2

The relationship between AKNA expression level and clinicopathological factors in 32 GC cases.

Characteristics		Expression of AKNA
		Low ()	High ()
Gender					0.685
Male	24	13 (54.2%)	11
Female	8	3 (37.5%)	5
Age(years)				4.800	0.028
≤60	12	9 (75.0%)	3
>60	20	7 (35.0%)	13
Borrmann’s types					0.433
I+II	9	6 (66.7%)	3
III	23	10 (43.5%)	13
Lauren’s types				0.533	0.465
Intestinal type	12	7 (58.3%)	5
Diffuse type	20	9 (45.0%)	11
Depth of invasion				3.463	0.063
T1~T3	11	3 (27.3%)	8
T4	21	13 (61.9%)	8
Ln metastasis				8.533	0.003
N0	12	2 (16.7%)	10
N1~N3	20	14 (70.0%)	6
Distant metastasis					1.000
M0	31	15 (48.4%)	16
M1	1	1 (100%)	0
TNM staging				1.166	0.280
I+II	13	5 (38.5%)	8
III+IV	19	11 (57.9%)	8

Fisher’s exact test. Ln.: lymph node.